Pharmaceutical Package Spectral Inspection for Non-Invasive Quality Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing quality control methods for pharmaceutical products are time-consuming, require qualified personnel, and involve invasive sampling, leading to high costs and potential batch discarding due to random sampling flaws.

Innovation Solution

A non-invasive method and system using electromagnetic radiation spectroscopy with optical spectrum analysis and artificial intelligence to inspect each pharmaceutical product individually, employing techniques like Principal Components Analysis and neural networks for rapid compliance assessment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If random sampling methods are used for quality control, then the inspection process is simpler to implement, but the analysis time increases and productivity decreases

Engineering Contradiction:
Improveease of implementationVSAvoidinspection speed
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The inspection system segments the quality control process by assigning unique identifiers to individual packages and inspecting each package separately rather than using batch sampling. This allows parallel processing and significantly increases inspection speed while maintaining simplicity through automated individual package tracking

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces manual sampling and laboratory analysis with an automated optical inspection system using electromagnetic radiation. This substitution eliminates the need for physical sample handling and chemical analysis, dramatically reducing inspection time while maintaining ease of operation through automated systems

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If invasive sampling methods are used for chemical analysis, then measurement precision is improved, but the packages are destroyed and loss of substance occurs

Engineering Contradiction:
Improvechemical analysis accuracyVSAvoidpackage destruction
Core Design Contradiction:
Measurement precisionVSLoss of substance

Solution Approach 1:

The patent replaces invasive mechanical sampling with non-invasive optical spectroscopy. The system uses electromagnetic radiation to obtain chemical information from packages without physical contact or destruction, eliminating substance loss while maintaining measurement precision through spectral analysis

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces electromagnetic radiation as an intermediary between the inspection system and the pharmaceutical product. This intermediary enables information extraction about chemical composition without direct physical interaction that would destroy the package, thus preventing loss of substance while maintaining analysis accuracy

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If traditional laboratory analysis is performed on sampled packages, then measurement precision is improved, but the duration of action increases and loss of time occurs

Engineering Contradiction:
Improvequality control accuracyVSAvoidinspection duration
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces time-consuming laboratory analysis with immediate optical spectroscopy. The inspection system performs chemical analysis in seconds using electromagnetic radiation rather than hours of laboratory processing, dramatically reducing inspection duration while maintaining precision through advanced spectral interpretation algorithms

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent performs inspection actions immediately at the production line rather than delaying for laboratory processing. By conducting analysis in situ and in real-time, the system eliminates transportation and waiting time, reducing total inspection duration while maintaining measurement precision through automated analysis

Inventive Principle:
Principle #10Preliminary action

4Device complexity

If random sampling is used for quality control, then device complexity is reduced, but reliability decreases due to false negatives in batch inspection

Engineering Contradiction:
Improveinspection system complexityVSAvoidbatch quality assurance
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent segments the batch into individual inspectable units with unique identifiers, allowing complete inspection of every package rather than random sampling. This increases reliability by eliminating false negatives while managing complexity through automated tracking and processing of individual package data

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The inspection system automatically processes and evaluates every package without requiring complex manual sampling protocols. The automated identification and inspection of each package simplifies the overall system complexity while dramatically improving reliability through comprehensive coverage of the entire batch

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid, non-invasive quality control of every pharmaceutical product, reducing analysis time and ensuring high reliability with minimal false positives.

Implementation Method 1

a) subjecting the pharmaceutical product to at least one electromagnetic radiation emitted towards the package (100) and b) detecting an optical spectrum generated in response to the impact of the electromagnetic radiation on the pharmaceutical product

Methodology Applied
Scientific EffectOptical spectrum generation: Absorption Spectroscopy

Data Source

PatentUS20250389645A1Method and system for inspecting a pharmaceutical product contained in a package
Publication Date: 2025.12.25 P B L SRL
  • US20250389645A1 patent drawing
  • US20250389645A1 patent drawing

AI summary

A method for inspecting a pharmaceutical product contained in a package, said method including the steps of: advancing a package of said pharmaceutical product along a transport path; during the advancement of the package along the transport path, subjecting the pharmaceutical product to at least one electromagnetic radiation emitted towards the package, and detecting an optical spectrum generated in response to the impact of the electromagnetic radiation on the pharmaceutical product; performing a spectral analysis of the detected optical spectrum.